Structure | Chemical Name | CAS | MF |
|
IFLAB-BB F2113-0039
|
16151-14-7
|
C9H11NO2
|
|
IFLAB-BB F0850-6764
|
37615-72-8
|
C14H12N2S
|
|
IFLAB-BB F2124-0090
|
17801-47-7
|
C9H9ClN4O
|
|
IFLAB-BB F2108-0155
|
95470-42-1
|
C7H9BrN2O2
|
|
IFLAB-BB F2124-0958
|
15058-72-7
|
C7H8O3
|
|
IFLAB-BB F1244-0003
|
469-73-8
|
C10H13KO3
|
|
IFLAB-BB F1294-0014
|
6211-59-2
|
C4H6O3S
|
|
IFLAB-BB F0915-4823
|
21277-97-4
|
C10H9NOS
|
|
IFLAB-BB F2124-0049
|
38275-59-1
|
C5H4ClN3O
|
|
IFLAB-BB F2124-0403
|
99847-70-8
|
C9H10BrN
|
|
IFLAB-BB F2124-0045
|
38275-37-5
|
C6H5BrN2O3
|
|
IFLAB-BB F1068-0046
|
100516-84-5
|
C5H8Br2O2S
|
|
IFLAB-BB F2124-0069
|
94924-82-0
|
C6H9N3O2S
|
|
IFLAB-BB F1303-0037
|
93104-84-8
|
C5H4INO2
|
|
IFLAB-BB F2108-0064
|
782439-26-3
|
C6H7ClN2
|
|
IFLAB-BB F2124-0071
|
94924-81-9
|
C9H15N3O2S
|
|
IFLAB-BB F0820-0242
|
91184-07-5
|
C6H6N4OS
|
|
IFLAB-BB F1703-0109
|
107269-65-8
|
C8H10ClN5
|
|
IFLAB-BB F2124-0060
|
54367-64-5
|
C10H7ClN2O2
|
|
IFLAB-BB F0037-7410
|
74920-46-0
|
C10H8N2O2S
|
|
IFLAB-BB F2125-0003
|
60980-82-7
|
C9H10ClNS
|
|
IFLAB-BB F2124-0125
|
25710-25-2
|
C7H9ClN4O2
|
|
IFLAB-BB F2124-0139
|
25710-23-0
|
C9H11ClN4O2
|
|
IFLAB-BB F2124-0138
|
54660-12-7
|
C6H7ClN4O2
|
|
IFLAB-BB F2124-0088
|
195252-56-3
|
C7H11ClN4
|
|
IFLAB-BB F0914-7227
|
61861-92-5
|
C14H22ClNO3
|
|
IFLAB-BB F2124-0130
|
326831-74-7
|
C7H9ClN4O2
|
|
IFLAB-BB F2108-0104
|
174615-69-1
|
C7H8ClNO
|
|
IFLAB-BB F2124-0124
|
25710-24-1
|
C6H7ClN4O2
|
|
IFLAB-BB F1076-0005
|
610275-02-0
|
C12H14N2O
|
|
IFLAB-BB F2124-0140
|
54660-14-9
|
C8H9ClN4O3
|
|
IFLAB-BB F1984-0168
|
86277-98-7
|
C11H8O5
|
|
IFLAB-BB F2108-0146
|
173032-58-1
|
C13H17NO4S
|
|
IFLAB-BB F2124-0044
|
30321-94-9
|
C6H5BrN2O4S
|
|
IFLAB-BB F2124-0129
|
492464-18-3
|
C8H11ClN4O2
|
|
IFLAB-BB F2124-0156
|
1131-14-2
|
C6H7ClN4O2
|
|
IgA, lambda, Human Isotype Control (HRP)
|
|
|
|
IGA2 LAMBDA
|
|
|
|
IGA1 LAMBDA
|
|
|
|
IgA, lambda, Human Isotype Control (AP)
|
|
|
|
IgA, lambda, Human Isotype Control
|
|
|
|
IgA1, Lambda, Myeloma, Human
|
|
|
|
IGA,MABANTI-
|
|
|
|
IGA1,MABANTI-
|
|
|
|
IGA2,MABANTI-
|
|
|
|
IgAllSpecies
|
|
|
|
IGA, MOUSE
|
|
|
|
Iganidipine
|
119687-33-1
|
C28H38N4O6
|
|
IgA, Murine Isotype Control (PE/CY5)
|
|
|
|
IgA, Murine Isotype Control (PE)
|
|
|
|
IgA, Murine Isotype Control
|
|
|
|
IgA, Murine Isotype Control (PE/Cy7)
|
|
|
|
IgA, Murine Isotype Control (PE/Cy5.5)
|
|
|
|
IgA, Murine Isotype Control (FITC)
|
|
|
|
IgA, Murine Isotype Control (APC)
|
|
|
|
IgA, Murine Isotype Control (Biotin)
|
|
|
|
IgA, Murine Isotype Control (Azide Free)
|
|
|
|
IgA R
|
|
|
|
IgA, Rat (Texas Red)
|
|
|
|
IGA, RAT
|
|
|
|
Iga,Rabbit
|
|
|
|
IgA receptor
|
|
|
|
IgA- Ready to UseDetection System
|
|
|
|
I-FLICE ANTIBODY BLOCKING PEPTIDE
|
|
|
|
Iga,SecretoryPiece
|
|
|
|
IgA Sec Component, Mouse anti-Human
|
|
|
|
IgA, Secretory Component
|
|
|
|
IGA, SECRETORY POLYCLONAL ANTIBODY (A)
|
|
|
|
IgA, secretory receptor
|
|
|
|
Iga,SecretoryDimer
|
|
|
|
IgA (Texas Red)
|
|
|
|
IgA-specific serine endopeptidase
|
|
|
|
IgA-specific metalloendopeptidase
|
|
|
|
IGA, Α-SPECIFIC POLYCLONAL ANTIBODY (A)
|
|
|
|
[125I]GASTRIC INHIBITORY POLYPEPTIDE
|
|
|
|
Ig, CD79, B-Cell, B29, 33/40kD, Clone: ZL9-1, Mab anti-Human, frozen, IH/flow/ELISA/IP
|
|
|
|
IEVM protocol
|
|
|
|
IEV protocol
|
|
|
|
IFL1 protein
|
|
|
|
IgD 1
|
|
|
|
Ig,Chicken
|
|
|
|
IFN-alfa Kit
|
|
|
|
IFN-ALPHA PRIMER
|
|
|
|
IFN-ALPHA RAT
|
|
|
|
IFN-ALPHA-A/D HUMAN
|
|
|
|
IFN-alfa INSTANT Kit
|
|
|
|
IFN alpha Polyclonal Ab
|
|
|
|
IFLUMIC ACID
|
|
|
|
IFN-BETA (RAT)
|
|
|
|
IFN-BETA PRIMER
|
|
|
|
IgD (Biotin)
|
|
|
|
IFN consensus sequence binding protein
|
|
|
|
IgD, F(ab')2 (FITC)
|
|
|
|
IgD, F(ab')2 (HRP)
|
|
|
|
IgD, F(ab')2
|
|
|
|
IgD, Fc
|
|
|
|
IgD, Fc, Myeloma
|
|
|
|
IgD (FITC)
|
|
|
|
IgD (FITC) A
|
|
|
|
IFN gamma Polyclonal Antibody
|
|
|